Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1695 of 6351
-
Last hope: experimental drug tested in single child with rare brain disease
Disease control OngoingCree Leukoencephalopathy (CLE) is a rare and fatal neurodegenerative disorder predominantly affecting the Cree population in Northern Quebec. Characterized by progressive white matter degeneration, this condition leads to severe neurological impairment and decline, leading to pre…
Early phase 1 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a probiotic wake up your immune system?
Knowledge-focused CompletedClinical proof-of-concept study, comparing the acute immune impacts of 3 doses of a probiotic strain to a placebo. This study involves twenty-four participants, composed of healthy adults, who will be taking a placebo and 3 different doses of the probiotic at different times. Tes…
Sponsor: Natural Immune Systems Inc • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New hope for kids with rare Muscle-Weakening disease
Disease control Recruiting nowThe primary objective of this study is to assess the pharmacokinetics and pharmacodynamics of gefurulimab in pediatric participants with AChR+ gMG for the duration of the study.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental POTS drug targets racing heart in first human test
Symptom relief CompletedThis study is researching an experimental drug called REGN7544 (called "study drug"). The study is focused on participants with POTS. The aim of the study is to see how safe, tolerable, and effective the study drug is. The study is looking at several other research questions, i…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Can a common bile acid pill reverse stomach changes that lead to cancer?
Disease control Recruiting nowThe goal of this clinical trial is to investigate the efficacy of ursodeoxycholic acid in treating gastric intestinal metaplasia in Helicobacter pylori-negative adults. It will also learn about the safety of ursodeoxycholic acid. The main questions it aims to answer are: Does ur…
Phase 4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Blood test may predict sepsis death risk within 28 days
Diagnosis OngoingThe primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.
Sponsor: Bluejay Diagnostics, Inc. • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Leg cast clot risk: pills vs. shots in massive 10,000-Person trial
Prevention Recruiting nowThe goal of this clinical trial is to find out the clinical and cost effectiveness of Thromboprophylaxis in participants who have been placed in a plaster cast or splint after injury. The main questions it aims to answer are: * whether giving tablets to people at high risks of …
Phase 3 • Sponsor: Queen Mary University of London • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Can a simple puff before surgery keep kids breathing safely?
Prevention Recruiting nowThis randomized controlled study is to evaluate the effectiveness of inhaling penehyclidine hydrochloride in reducing perioperative respiratory adverse events in children at risk undergoing minor elective surgery.
Phase 4 • Sponsor: Sun Yat-sen University • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Real-World study tests new Parkinson's pump treatment
Disease control OngoingParkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective fos…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New study tests HPV vaccine effectiveness and At-Home screening for women with HIV
Knowledge-focused By invitation onlyThis study will examine both Human papillomavirus (HPV) vaccine effectiveness and Primary high-risk HPV PHS screening triage strategies in women living with HIV (WLHIV) by partnering with the Pediatric HIV/AIDs Cohort Study (PHACS) led, in part, by our investigative team. Among W…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Matching depression treatment to your symptoms: a smarter approach?
Disease control By invitation onlyThis study aims to assess whether phenotyping-guided intervention selection is superior to intervention selection without phenotyping guidance (i.e., routine clinician and patient judgment regarding treatment selection) for depression.
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 26, 2026 13:50 UTC
-
Could a smartphone game boost recovery after knee replacement?
Disease control CompletedThe aim of this clinical trial is to determine the effect of a mobile-compatible web-based gamified application (Game-App-KNEE) developed for post-operative care of total knee replacement (TKA) surgery on functional outcomes and recovery status. Based on this, the hypotheses of …
Sponsor: Akdeniz University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could breast cancer survivors face higher colon cancer risk?
Knowledge-focused CompletedBreast cancer survivors may be at increased risk for developing colorectal polyps and colorectal cancer because of shared genetic, hormonal, and lifestyle-related risk factors. However, the prevalence of colorectal neoplasia in women with breast cancer has not been clearly establ…
Sponsor: Haydarpasa Numune Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Brain training boosts Ketamine's Mood-Lifting power?
Symptom relief Recruiting nowIn a sample of patients already receiving ketamine (or esketamine) treatment as part of their clinical care, this project seeks to test whether we can enhance and/or extend (es)ketamine's rapid effects by introducing helpful information delivered by a computer-based cognitive tra…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Could a sweet drink before surgery speed up recovery?
Symptom relief Recruiting nowThe goal of this interventional study is to learn if carbohydrates loading improves overall outcome in adolescent patient undergoing scoliosis curgery The main questions of the study are as follows: 1. Does carbohydrates loading improves gastrointestinal related problems such a…
Sponsor: University of Malaya • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Brain zaps may ease Parkinson's movement woes
Symptom relief Recruiting nowThe investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.
Sponsor: Sanford Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New shot could ease skin tightening in rare disease
Disease control Recruiting nowThe main purpose of this study is to evaluate the effect and safety of efgartigimod PH20 SC compared to placebo in adults with systemic sclerosis. The study consists of a screening period, a treatment period of up to 48 weeks and a safety follow-up period. After the screening per…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
One size Doesn't fit all: new trial tests tailored blood thinners for joint replacement patients
Disease control Recruiting nowAfter hip or knee replacement all patients receive a standardized treatment with blood thinners, this medication is called thrombosis prophylaxis. However, despite this standard treatment some individuals still develop venous thrombosis (VTE), while others experience bleeding. Th…
Phase 4 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Fish or pills? study tests best way to boost young hearts
Prevention CompletedCardiovascular disease (CVD) is one of the major causes of mortality, however, it is estimated that approximately 75% of all cases are preventable. Previous evidence has shown higher blood concentrations of n-3 polyunsaturated fatty acids (PUFAs) are associated with a lower risk …
Sponsor: University of Ulster • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Can an antihistamine–steroid combo pill beat standard allergy meds?
Symptom relief CompletedPhase IIIb , longitudinal, multicenter, randomized, double-blind, to evaluate efficacy and safety of the fixed-dose combination of Desloratadine 5 mg / Betamethasone 0.25 mg versus Desloratadine 5 mg monotherapy as treatment for symptoms associated with allergic rhinitis.
Phase 3 • Sponsor: Laboratorios Silanes S.A. de C.V. • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC